Photo of Paolo Tarantino taken from Twitter
Apr 10, 2024, 05:00
Paolo Tarantino: Our study on the prognosis of small TNBCs is out in NPJ Journals
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post on X:
“Our study on the prognosis of small TNBCs is out in NPJ Journals Breast. Among 8601 pts with stage I TNBC in SEER, we found excellent 5-year outcomes, with a significant BCSS benefit for chemo in pT1c. Benefit less clear in tumors ≤1cm: biomarkers needed! ”
Read further.
Source: Paolo Tarantino/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 21, 2025, 19:55
Apr 21, 2025, 19:12
Apr 21, 2025, 18:19
Apr 21, 2025, 18:00
Apr 21, 2025, 17:40
Apr 21, 2025, 17:35
Apr 21, 2025, 17:29
Apr 21, 2025, 17:21